COVID-19 vaccine boosters are due to roll out in late September — and some immunocompromised people are eligible right now. Here’s what you need to know before you get that extra jab.
While COVID-19 vaccines continue to offer remarkable protection against severe illness, hospitalization, and death, even against the delta variant, recent research has shown their overall effectiveness wanes over time.
After reviewing the data and debating the issue, on September 24 the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) endorsed a third dose for certain people who have already received two doses of the Pfizer-BioNTech vaccine. Those who qualify include people age 65 and older and individuals age 18 to 64 with underlying medical conditions that put them at high risk of severe COVID-19.
Disclaimer: Content on our site is provided for information purposes only; therefore, this material is not intended to advise. This information includes a link to a site that is maintained by another; MS Monterey is not responsible for content on this site. Please remember to consult with your doctor or health care provider before making any changes to your medication(s) or medical regimen.
Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system).
In MS, the immune system attacks the protective sheath (myelin) that covers nerve fibers and causes communication problems between your brain and the rest of your body. Eventually, the disease can cause permanent damage or deterioration of the nerves.
Signs and symptoms of MS vary widely and depend on the amount of nerve damage and which nerves are affected. Some people with severe MS may lose the ability to walk independently or at all, while others may experience long periods of remission without any new symptoms.
There’s no cure for multiple sclerosis. However, treatments can help speed recovery from attacks, modify the course of the disease and manage symptoms.